Quality of care in African-American patients admitted for congestive heart failure at a university teaching hospital

American Journal of Cardiology

Volumn 97, Issue 5, 2006, Pages 690-693

  Ilksoy, Nurcan ^a   Moore, Renee H ^b   Easley, Kirk ^b   Jacobson, Terry A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE;

ADULT; AFRICAN AMERICAN; AGED; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE QUALITY; HEART LEFT VENTRICLE FAILURE; HOSPITAL DISCHARGE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SODIUM RESTRICTION; SYSTOLE; TEACHING HOSPITAL;

EID: 32844463453     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.09.116     Document Type: Article

References (20)

1. M. Packer, J.N. Cohn Consensus recommendation for the management of chronic heart failure Am J Cardiol 83 1999 1A 38A
2. SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
3. S. Hjalmarson, B. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, J. Kjekshus, J. Wilkstrand, D. El Allaf, J. Vitovec, J. Aldershvile Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) MERIT-HF Study Group Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure JAMA 283 2000 1295 1302
4. M.A. Konstam, K. Dracup, D.W. Baker, M.B. Bottorff Heart failure: evaluation and care of patients with left ventricular systolic dysfunction: Clinical Practice Guideline, No. 1 2001 Agency for Health Care Policy and Research, Public Health Service, United States Department of Health and Human Services Rockville, Maryland
5. S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldman, G.S. Francis, T.G. Ganiats, S. Goldstein, G. Gregoratos, M.L. Jessup ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult J Am Coll Cardiol 38 2001 2101 2113
6. M.D. Cabana, C.S. Rand, N.R. Powe, W.A. Wu, M.H. Wilson, P.A. Abboud, H.R. Rubin Why don't physicians follow clinical practice guidelines? A framework for improvement JAMA 282 1999 1458 1465
7. S.E. Reis, R. Holubkov, D. Edmundowicz, D.M. McNamara, K.A. Zell, K.M. Detre, A.M. Feldman Treatment of patients admitted to the hospital with congestive heart failure specialty-related disparities in practice patterns and outcomes J Am Coll Cardiol 30 1997 733 738
8. A. Nohria, Y.T. Chen, D.J. Morton, R. Walsh, P.H. Vlasses, H.M. Krumholz Quality of care for patients hospitalized with heart failure at academic medical centers Am Heart J 137 1999 1028 1034
9. H.M. Krumholz, Y. Wang, E.M. Parent, J. Mockalis, M. Petrillo, M.J. Radford Quality of care for elderly patients hospitalized with heart failure Arch Intern Med 157 1997 2242 2247
10. P.K. Lindenauer, R. Chehabeddine, P. Pekow, J. Fitzgerald, E.M. Benjamin Quality of care for patients hospitalized with heart failure Arch Intern Med 162 2002 1251 1256
11. Joint Commission on Accreditation of Healthcare Organizations. Core measures overview. Available at: http://www.jcaho.org/pms/core+measures/ hf_overview.htm. Accessed September 10, 2005.
12. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
13. G.C. Fonarow, M. Gheorghiade, W.T. Abraham Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review Am J Cardiol 94 2004 1155 1160
14. S.F. Jencks, E.D. Huff, T. Cuerdon Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001 JAMA 289 2003 305 312
15. S.S. Rathore, J.M. Foody, Y. Wang, G.L. Smith, J. Herrin, F.A. Masoudi, P. Wolfe, E.P. Havranek, D.L. Ordin, H.M. Krumholz Race, quality of care and outcomes of elderly patients hospitalized with heart failure JAMA 289 2003 2517 2524
16. N.L. Smith, J.D. Chan, T.D. Rea, K.L. Wiggins, J.S. Gottdiener, T. Lumley, B.M. Psaty Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure Am Heart J 148 2004 710 717
17. J.L. Cox, S.A. Ramer, D.S. Lee, K. Humphries, L. Pilote, L. Svenson, J.V. Tu Canadian Cardiovascular Outcomes Research Team Investigators Pharmacological treatment of congestive heart failure in Canada a description of care in five provinces Can J Cardiol 21 2005 337 343
18. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr, K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel African-American Heart Failure Trial Investigators Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
19. N.R. Kressin, L.A. Petersen Racial differences in the use of invasive cardiovascular procedures review of the literature and prescription for future research Ann Intern Med 135 2001 352 366
20. A.M. Epstein, J.Z. Ayanzian Racial disparities in medical care N Engl J Med 344 2001 1471-1433